Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination–deficient cancer models

Manal Mehibel(Stanford University), Amato J. Giaccia(Stanford University)
Journal of Clinical Investigation
June 1, 2021
Cited by 37


Related Papers